{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:42:31Z","timestamp":1791024151715,"version":"4.1.0"},"reference-count":61,"publisher":"Japanese Circulation Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2009]]},"DOI":"10.1253\/circj.cj-09-0710","type":"journal-article","created":{"date-parts":[[2009,11,25]],"date-time":"2009-11-25T07:57:41Z","timestamp":1259135861000},"page":"2192-2197","source":"Crossref","is-referenced-by-count":59,"title":["Angiopoietin-Like Proteins  Potential Therapeutic Targets for Metabolic Syndrome and Cardiovascular Disease"],"prefix":"10.1253","volume":"73","author":[{"given":"Yuichi","family":"Oike","sequence":"first","affiliation":[{"name":"Department of Molecular Genetics, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhisa","family":"Tabata","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Nephrology, Department of Internal Medicine, School of Medicine, Keio University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.37.26523"},{"key":"2","unstructured":"2. Dhanabal M, LaRochelle WJ, Jeffers M, Herrmann J, Rastelli L, McDonald WF, et al. Angioarrest An antiangiogenic protein with tumor-inhibiting properties. Cancer Res 2002; 62: 3834-3841."},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0501902102"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1038\/ng814"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109768200"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M004029200"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.20.14.5343-5349.2000"},{"key":"8","unstructured":"8. Ito Y, Oike Y, Yasunaga K, Hamada K, Miyata K, Matsumoto S, et al. Inhibition of angiogenesis and vascular leakiness by angiopoietin-related protein 4. Cancer Res 2003; 63: 6651-6657."},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1042\/0264-6021:3460603"},{"issue":"3","key":"10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s100380300025","volume":"48","author":"ZENG L","year":"2003","ISSN":"https:\/\/id.crossref.org\/issn\/1434-5161","issn-type":"print"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Oike Y, Yasunaga K, Suda T. Angiopoietin-related\/angiopoietin-like proteins regulate angiogenesis. Int J Hematol 2004; 80: 21-28.","DOI":"10.1532\/IJH97.04034"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1531901100"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Katoh Y, Katoh M. Comparative integromics on Angiopoietin family members. Int J Mol Med 2006; 17: 1145-1149.","DOI":"10.3892\/ijmm.17.6.1145"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Oike Y, Ito Y, Maekawa H, Morisada T, Kubota Y, Akao M, et al. Angiopoietin-related growth factor (AGF) promotes angiogenesis. Blood 2004; 103: 3760-3765.","DOI":"10.1182\/blood-2003-04-1272"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M302861200"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M203215200"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M500005-JLR200"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M400138-JLR200"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Oike Y, Akao M, Kubota Y, Suda T. Angiopoietin-like proteins: Potential new targets for metabolic syndrome therapy. Trends Mol Med 2005; 11: 473-479.","DOI":"10.1016\/j.molmed.2005.08.002"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Hato T, Tabata M, Oike Y. The role of angiopoietin-like proteins in angiogenesis and metabolism. Trends Cardiovasc Med 2008; 18: 6-14.","DOI":"10.1016\/j.tcm.2007.10.003"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Oike Y, Akao M, Yasunaga K, Yamauchi T, Morisada T, Ito Y, et al. Angiopoietin-related growth factor antagonizes obesity and insulin resistance. Nat Med 2005; 11: 400-408.","DOI":"10.1038\/nm1214"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Tabata M, Kadomatsu T, Fukuhara S, Miyata K, Ito Y, Endo M, et al. Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metab 2009; 10: 178-188.","DOI":"10.1016\/j.cmet.2009.08.003"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.13.1549"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1172\/JCI34260"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Maron DJ, Fazio S, Linton MF. Current perspectives on statins. Circulation 2000; 101: 207-213.","DOI":"10.1161\/01.CIR.101.2.207"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66378-7"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.nutr.24.012003.132155"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-08-0337"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Takeno M, Yasuda S, Otsuka Y, Morii I, Kawamura A, Yano K, et al. Impact of metabolic syndrome on the long-term survival of patients with acute myocardial infarction: Potential association with C-reactive protein. Circ J 2008; 72: 415-419.","DOI":"10.1253\/circj.72.415"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Ebert T, Bachmann A, Lossner U, Kratzsch J, Bluher M, Stumvoll M, et al. Serum levels of angiopoietin-related growth factor in diabetes mellitus and chronic hemodialysis. Metabolism 2009; 58: 547-551.","DOI":"10.1016\/j.metabol.2008.11.016"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1210\/er.2002-0012"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Kitazawa M, Ohizumi Y, Oike Y, Hishinuma T, Hashimoto S. Angiopoietin-related growth factor suppresses gluconeogenesis through the Akt\/forkhead box class O1-dependent pathway in hepatocytes. J Pharmacol Exp Ther 2007; 323: 787-793.","DOI":"10.1124\/jpet.107.127530"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Legry V, Goumidi L, Huyvaert M, Cottel D, Ferrieres J, Arveiler D, et al. Association between angiopoietin-like 6 (ANGPTL6) gene polymorphisms and metabolic syndrome-related phenotypes in the French MONICA Study. Diabetes Metab 2009; 35: 287-292.","DOI":"10.1016\/j.diabet.2008.12.005"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Urano T, Ito Y, Akao M, Sawa T, Miyata K, Tabata M, et al. Angiopoietin-related growth factor enhances blood flow via activation of the ERK1\/2-eNOS-NO pathway in a mouse hind-limb ischemia model. Arterioscler Thromb Vasc Biol 2008; 28: 827-834.","DOI":"10.1161\/ATVBAHA.107.149674"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1210\/rp.56.1.265"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Takano H, Komuro I. Peroxisome proliferator-activated receptor gamma and cardiovascular diseases. Circ J 2009; 73: 214-220.","DOI":"10.1253\/circj.CJ-08-1071"},{"key":"37","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biochem.76.060305.151318"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Michelsen KS, Doherty TM, Shah PK, Arditi M. TLR signaling: An emerging bridge from innate immunity to atherogenesis. J Immunol 2004; 173: 5901-5907.","DOI":"10.4049\/jimmunol.173.10.5901"},{"key":"39","doi-asserted-by":"publisher","DOI":"10.1172\/JCI28898"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Smiley ST, King JA, Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 2001; 167: 2887-2894.","DOI":"10.4049\/jimmunol.167.5.2887"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Higashi Y, Noma K, Yoshizumi M, Kihara Y. Endothelial function and oxidative stress in cardiovascular diseases. Circ J 2009; 73: 411-418.","DOI":"10.1253\/circj.CJ-08-1102"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Farhat N, Thorin-Trescases N, Voghel G, Villeneuve L, Mamarbachi M, Perrault LP, et al. Stress-induced senescence predominates in endothelial cells isolated from atherosclerotic chronic smokers. Can J Physiol Pharmacol 2008; 86: 761-769.","DOI":"10.1139\/Y08-082"},{"key":"43","doi-asserted-by":"publisher","DOI":"10.1253\/circj.71.1173"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Elliott P, Chambers JC, Zhang W, Clarke R, Hopewell JC, Peden JF, et al. Genetic loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 2009; 302: 37-48.","DOI":"10.1001\/jama.2009.954"},{"key":"45","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67528-9"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Sun H, Zheng JM, Chen S, Zeng CH, Liu ZH, Li LS. Enhanced expression of ANGPTL2 in the microvascular lesions of diabetic glomerulopathy. Nephron Exp Nephrol 2007; 105: e117-e123.","DOI":"10.1159\/000100493"},{"key":"47","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005080859"},{"key":"48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00367.x"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Kaur C, Foulds WS, Ling EA. Blood-retinal barrier in hypoxic ischaemic conditions: Basic concepts, clinical features and management. Prog Retin Eye Res 2008; 27: 622-647.","DOI":"10.1016\/j.preteyeres.2008.09.003"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Keith B, Simon MC. Hypoxia-inducible factors, stem cells, and cancer. Cell 2007; 129: 465-472.","DOI":"10.1016\/j.cell.2007.04.019"},{"key":"51","doi-asserted-by":"publisher","DOI":"10.1038\/nature04871"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Orimo A, Weinberg RA. Stromal fibroblasts in cancer: A novel tumor-promoting cell type. Cell Cycle 2006; 5: 1597-1601.","DOI":"10.4161\/cc.5.15.3112"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Crawford Y, Kasman I, Yu L, Zhong C, Wu X, Modrusan Z, et al. PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment. Cancer Cell 2009; 15: 21-34.","DOI":"10.1016\/j.ccr.2008.12.004"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569-578.","DOI":"10.1016\/S0140-6736(08)60269-X"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Becker S, Dossus L, Kaaks R. Obesity related hyperinsulinaemia and hyperglycaemia and cancer development. Arch Physiol Biochem 2009; 115: 86-96.","DOI":"10.1080\/13813450902878054"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Marchesini G, Moscatiello S, Di Domizio S, Forlani G. Obesity-associated liver disease. J Clin Endocrinol Metab 2008; 93: S74-S80.","DOI":"10.1210\/jc.2008-1399"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Li D, Morris JS, Liu J, Hassan MM, Day RS, Bondy ML, et al. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA 2009; 301: 2553-2562.","DOI":"10.1001\/jama.2009.886"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Freedland SJ, Wen J, Wuerstle M, Shah A, Lai D, Moalej B, et al. Obesity is a significant risk factor for prostate cancer at the time of biopsy. Urology 2008; 72: 1102-1105.","DOI":"10.1016\/j.urology.2008.05.044"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Hatsuda S, Shoji T, Shinohara K, Kimoto E, Mori K, Fukumoto S, et al. Association between plasma angiopoietin-like protein 3 and arterial wall thickness in healthy subjects. J Vasc Res 2007; 44: 61-66.","DOI":"10.1159\/000098153"},{"key":"60","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2008.12.018"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Folsom AR, Peacock JM, Demerath E, Boerwinkle E. Variation in ANGPTL4 and risk of coronary heart disease: The Atherosclerosis Risk in Communities Study. Metabolism 2008; 57: 1591-1596.","DOI":"10.1016\/j.metabol.2008.06.016"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/circj\/73\/12\/73_CJ-09-0710\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T03:51:25Z","timestamp":1616644285000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/circj\/73\/12\/73_CJ-09-0710\/_article"}},"subtitle":["Potential Therapeutic Targets for Metabolic Syndrome and Cardiovascular Disease"],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":61,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-09-0710","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009]]}}}